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IntroductIon
NK cells recognize and eliminate virus-infected cells and 
transformed cells by using a repertoire of NK cell receptors 
that regulates their activation and effector functions (Lanier, 
2005). NK cells were traditionally classified as innate immune 
cells that respond rapidly against pathogens, but were consid-
ered short-lived and unable to differentiate into long-lived 
memory cells. Accumulating evidence, however, demonstrates 
that NK cells possess adaptive immune features, which in-
clude antigen-specific clonal expansion and differentiation 
into self-renewing, long-lived memory NK cells (O’Leary 
et al., 2006; Sun et al., 2009, 2010; Min-Oo et al., 2013). 
In mouse models, NK cells that are activated by pathogens, 
haptens, alloantigens, or a combination of cytokines, and 
are subsequently capable of differentiating into memory or 
memory-like NK cells with augmented effector functions in 
response to a variety of secondary stimulations as compared 
with naive NK cells (O’Leary et al., 2006; Cooper et al., 2009; 
Sun et al., 2009; Nabekura and Lanier, 2014).
We have demonstrated that mouse NK cells expressing 
the activating Ly49H receptor, which specifically recognizes 
the m157 mouse cytomegalovirus (MCMV) glycoprotein on 
the infected cells (Arase et al., 2002; Smith et al., 2002), un-
dergo activation, a robust expansion, contraction, differentia-
tion into a long-lived memory subset with enhanced effector 
functions, and persistence for several months after MCMV in-
fection in a manner similar to antigen-specific T cells (Sun et 
al., 2009, 2010). These MCMV-primed memory Ly49H+ NK 
cells are capable of mounting a secondary antigen-specific re-
call response and provide effective host protection against re-
challenge with MCMV infection (Sun et al., 2009). We have 
also demonstrated that mouse NK cells bearing the activating 
Ly49D receptor, which is specific for H-2Dd, preferentially 
expand and differentiate into memory NK cells when chal-
lenged with allogeneic H-2Dd–expressing cells in the con-
text of an inflammatory environment (Nabekura and Lanier, 
2014). Like Ly49H+ NK cells generated during MCMV in-
fection, alloantigen-primed Ly49D+ NK cells exert enhanced 
effector functions and proliferate in response to a secondary 
alloantigen stimulation (Nabekura and Lanier, 2014). These 
activating receptor ligand–driven memory NK cell sub-
sets share a memory immunophenotype (KLRG1highLy6C+ 
DNAM-1lowCD11b+CD27−), mount a secondary response 
when rechallenged with the same antigenic stimulation, and 
demonstrate augmented effector functions in vitro. The gen-
eration of memory Ly49D+ and Ly49H+ NK cells requires 
signals transmitted by the immunoreceptor tyrosine-based 
activation motif (ITAM)–containing DAP12 adapter and by 
the proinflammatory cytokine IL-12 (Sun et al., 2009, 2012; 
Nabekura and Lanier, 2014). In humans, the activating CD94-
NKG2C receptor has been implicated in the NK cell response 
to human cytomegalovirus (HCMV). The existence of human 
natural killer (nK) cells provide important host defense and can generate long-lived memory nK cells. Here, by using novel 
transgenic mice carrying inducible cre expressed under the control of ncr1 gene, we demonstrated that two distinct long-lived 
nK cell subsets differentiate in a mouse model of cytomegalovirus (McMV) infection. nK cells expressing the McMV-specific 
Ly49H receptor differentiated into memory nK cells by an activating signaling through Ly49H and Ly49H− nK cells differen-
tiated into cytokine-activated nK cells by exposure to inflammatory cytokines during infection. Interleukin-12 is indispensable 
for optimal generation of both antigen-specific memory nK cells and cytokine-activated nK cells. McMV-specific memory nK 
cells show enhanced effector function and augmented antitumor activity in vivo as compared with cytokine-activated nK cells, 
whereas cytokine-activated nK cells exhibited a more robust response to IL-15 and persisted better in an McMV-free envi-
ronment. these findings reveal that nK cells are capable of differentiation into distinct long-lived subsets with different 
functional properties.
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memory NK cells is supported by an increased frequency of 
CD94-NKG2ChighCD57+ NK cells in HCMV-seropositive 
human subjects as compared with HCMV-seronegative indi-
viduals (Lopez-Vergès et al., 2011). Similar to the response of 
Ly49H+ NK cells during MCMV infection in mice, human 
NK cells bearing NKG2C expand during acute HCMV in-
fection, up-regulate expression of NKG2C and the matura-
tion marker CD57, and exert enhanced IFN-γ production in 
response to target cells (Lopez-Vergès et al., 2011; Foley et al., 
2012b). These HCMV-induced CD94-NKG2ChighCD57+ 
NK cells show long-term persistence in HCMV-seropositive 
individuals and preferentially proliferate in response to reacti-
vation of HCMV in allogeneic hematopoietic cell and organ 
transplant recipients (Gumá et al., 2004; Lopez-Vergès et al., 
2011; Foley et al., 2012a,b).
Activation of NK cells by cytokines alone in vitro leads 
to the generation of NK cells with memory-like properties 
(Cooper et al., 2009). Mouse and human NK cells preac-
tivated with a combination of IL-12, IL-15, and IL-18 ex-
hibit enhanced IFN-γ production, but not cytotoxicity, upon 
restimulation with IL-12 and IL-15 or activating receptor 
ligation as compared with NK cells pretreated with IL-15 
alone (Cooper et al., 2009; Romee et al., 2012). These cyto-
kine-induced memory-like NK cells highly express IL-2Rα, 
and they persist and demonstrate sustained IFN-γ production 
in vivo when they are adoptively transferred into lympho-
penic recipient mice (Cooper et al., 2009; Ni et al., 2012; 
Romee et al., 2012; Leong et al., 2014). Although the phe-
notype of mouse cytokine-induced memory-like NK cells 
is not well defined (Cooper et al., 2009; Ni et al., 2012), 
human cytokine-induced memory-like NK cells exhibit a 
distinct phenotype compared with naive NK cells, includ-
ing high expression of CD94, NKG2A, CD69, and NKp46 
(Romee et al., 2012). It is unknown whether the in vitro 
cytokine–induced memory-like NK cells are representative 
of NK cells generated in physiological situations in vivo, for 
example during infection or in other inflammatory envi-
ronments. A prior study reported that mouse NK cells do 
not undergo proliferation and maturation in peripheral tis-
sues during infection with influenza virus (van Helden et al., 
2012). However, adoptively transferred NK cells from influ-
enza virus–infected mice survive longer than naive NK cells 
from uninfected mice and undergo homeostatic proliferation 
in naive recipient mice (van Helden et al., 2012). NK cells 
from respiratory syncytial virus (RSV)–infected mice have 
the same properties (van Helden et al., 2012), suggesting that 
these long-lived NK cells with proliferative activity are gen-
erated not in response to virus-specific antigens but rather 
may be caused by exposure to inflammatory cytokines during 
these viral infections. Unlike the CD94-NKG2ChighCD57+ 
memory NK cells in HCMV-seropositive humans, the in 
vivo counterparts of in vitro–generated cytokine-induced 
memory-like NK cells in humans have not been reported. 
In the present study, by using novel bacterial artificial chro-
mosome (BAC) transgenic mice carrying an inducible Cre 
recombinase that is expressed under the control of the mouse 
Ncr1 gene, we addressed whether NK cells differentiate into 
distinct subsets of long-lived antigen-specific and non–anti-
gen-specific NK cells with different functional properties and 
fates in a model of MCMV infection.
resuLts
Generation of nKp46-creert2 transgenic mice
Our prior studies have used transfer of MCMV-specific 
Ly49H+ NK cells into Ly49H-deficient or DAP12-deficient 
mice, which lack functionally competent Ly49H+ NK cells, 
to track their fate during MCMV infection (Sun et al., 2009; 
Nabekura et al., 2014). A technical limitation of the transfer 
method is the detection of the small number of donor Ly49H+ 
NK cells in recipient mice over the course of MCMV infec-
tion. Furthermore, the differentiation and fate of Ly49H− NK 
cells in response to inflammatory cytokines during MCMV 
infection remains to be addressed. To address these issues, we 
developed a transgenic mouse carrying the CreERT2 re-
combinase expressed under the control of the mouse Ncr1 
gene, which is encoded in a bacterial artificial chromosome 
(NKp46-CreERT2 Tg mice; Fig.  1  A). NKp46-CreERT2 
Tg mice were intercrossed with Rosa26-tdTomato C57BL/6 
(B6) mice (their Rosa26 loci are derived from 129S6 chro-
mosome 6 containing the 129S6 NK gene cluster, which 
lacks the Klra8 gene encoding Ly49H) or with Rosa26-YFP 
B6 mice (their Rosa26 loci are derived from B6 chromosome 
6 containing the B6 NK gene cluster with the Klra8 gene). 
These mice express tdTomato or YFP, respectively, upon 
CreERT2-mediated excision of the loxP-floxed stop codon 
in the Rosa26 loci only after tamoxifen administration. These 
NKp46-CreERT2 Tg mice with the Rosa26-tdTomato or 
Rosa26-YFP allele were obtained at Mendelian frequencies, 
developed normally with fertility, and exhibited no significant 
variations in frequencies of immune cell subsets, including 
NK cells, in the lymphoid tissues compared with WT litter-
mate controls without the BAC construct (unpublished data). 
NK cells in these NKp46-CreERT2 Tg mice and WT litter-
mates expressed equivalent amounts of NKp46 on their cell 
surfaces (unpublished data). NK cells were identified as DX5+ 
NKp46+TCRβ−B220− lymphocytes in the spleen, blood, 
liver, and bone marrow. 20–40% of NK cells in the spleens 
of NKp46-CreERT2 Tg mice carrying a heterozygous Rosa26- 
tdTomato allele were positive for tdTomato after oral admin-
istration of tamoxifen (Fig. 1 B and not depicted). T cells, B 
cells, and non-T, non-B, non-NK cells (i.e., predominantly 
myeloid cells) did not express tdTomato (Fig. 1 B) Consistent 
with a prior study using a NKp46-iCre knock-in mouse to 
fate map NK cells expressing NKp46 (Narni-Mancinelli et 
al., 2011), immature NK cells and mature NK cells, but not 
precursor NK cells, in the bone marrow expressed tdTomato 
after tamoxifen administration (Fig.  1 C). NK cells express 
the pan-NK cell marker DX5, whereas liver-resident NK 
cells (also referred to as innate lymphoid cell 1 [ILC1]) do 
not express DX5. Additionally, some other ILC subsets, e.g., 
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some ILC3, express NKp46 (Peng et al., 2013; Serafini et al., 
2015). After tamoxifen treatment, ILC1 and NKp46+ ILC3 
were positive for tdTomato, but at a lower frequency than NK 
cells in the liver (Fig. 1 D). NKp46-CreERT2 Tg mice were 
intercrossed with Rosa26-YFP B6 mice bearing the B6-de-
rived NK gene cluster, including the Klra8 gene on chromo-
some 6, which encodes Ly49H. 10–20% of splenic NK cells 
in NKp46-CreERT2 Tg x Rosa26-YFP mice expressed YFP 
after tamoxifen administration (Fig. 1, E and F). After tamox-
ifen treatment, we observed the same pattern of expression 
of YFP and tdTomato in NKp46+ cells, including NK cells, 
liver-resident ILC1, and NKp46+ ILC3, in mice having the 
Rosa26-YFP or Rosa26-dtTomato alleles (unpublished data).
McMV infection induces differentiation of memory Ly49H+ 
nK cells and cytokine-activated Ly49H− nK cells
We investigated the fate of YFP+Ly49H+ NK cells in NKp46-
CreERT2 x Rosa26-YFP Tg mice after tamoxifen admin-
istration during the course of MCMV infection. When 
NKp46-CreERT2 Tg mice carrying a heterozygous Rosa26- 
YFP allele were infected with MCMV on day 0 and treated 
with tamoxifen on days 0–4, YFP+ NK cells expressing 
Ly49H preferentially expanded and survived comparably to 
YFP−Ly49H+ NK cells (Fig. 2 A), allowing us to track the 
MCMV-primed long-lived NK cells as YFP+ NK cells in 
MCMV-infected mice. Consistent with our prior studies 
using Ly49H+ NK cells adoptively transferred into congenic 
recipients (Sun et al., 2009; Nabekura et al., 2014), these 
YFP+Ly49H+ NK cells persisted for >1 mo after MCMV 
infection and differentiated into MCMV-primed long-lived 
memory YFP+Ly49H+ NK cells expressing high levels of 
KLRG1 (Fig. 2 B). In contrast, <1% of YFP+ NK cells in 
naive uninfected NKp46-CreERT2 x Rosa26-YFP Tg mice 
expressed high levels of KLRG1 (Fig. 2 B). Unexpectedly, a 
subpopulation of YFP+Ly49H−KLRG1high NK cells in the 
MCMV-infected mice also survived for >1 mo after the in-
fection (Fig. 2 B). These long-lived cytokine-activated YFP+ 
Ly49H−KLRG1high NK cells that did not undergo clonal ex-
pansion possessed a lower frequency of cells expressing a mem-
ory cell phenotype (KLRG1highLy6C+DNAM-1low) compared 
with MCMV-specific YFP+Ly49H+KLRG1high memory NK 
cells (Fig. 2 C). When analyzed ex vivo 1 mo post infection 
(p.i.), both YFP+Ly49H+KLRG1high memory NK cells and the 
cytokine-activated YFP+Ly49H−KLRG1high NK cells showed 
a mature NK cell phenotype (CD11b+CD27−) and an in-
creased expression of Granzyme B (Fig. 2, C and D). Com-
Figure 1. nK cells in nKp46-creert2 tg mice carrying the rosa26-td-
tomato allele or the rosa26-YFP alleles express tdtomato or YFP after 
tamoxifen administration. (A) Schematic representation of the strategy 
used to generate NKp46-CreERT2 Tg mice. An IRES-CreERT2 cassette was 
inserted into the 3′ untranslated region of exon 7 of the mouse Ncr1 gene 
on mouse chromosome 7 in a C57BL/6 BAC. (B–D) NKp46-CreERT2 Tg mice 
with a heterozygous Rosa26-tdTomato allele were treated with tamoxifen 
for 5 consecutive days and immune cells were analyzed after the last tamox-
ifen administration. (B) Expression of tdTomato in NK cells (DX5+NKp46+T-
CRβ−B220−); T cells (NKp46−TCRβ+B220−); B cells (NKp46−TCRβ−B220+); 
and non-NK, non-T, and non-B cells (NKp46−TCRβ−B220−, predomi-
nantly myeloid cells) in the spleen. (C) Expression of tdTomato in NK 
precursor cells (TCRβ−CD19−CD11b−DX5−NKp46−CD122+) and imma-
ture (CD11b−CD27+), intermediate (CD11b+CD27+), and mature (CD11b+ 
CD27+) NK cells (TCRβ−CD19−DX5+NKp46+) in the bone marrow. (D) Ex-
pression of tdTomato in NK cells (TCRβ−CD19−DX5+NKp46+CD122+), 
liver-resident NK cells (TCRβ−CD19−DX5−NKp46+CD122+), ILC1 
(TCRβ−CD19−DX5−NKp46+CD11b−CD27+CD122low), and NKp46+ ILC3 
(TCRβ−CD19−DX5−NKp46+CD11b−CD27−CD122low that are potentially ILC3) 
in the liver. Data are representative of two to three experiments (n = 2 in 
each experiment). (E and F) NKp46-CreERT2 Tg mice with a heterozygous 
Rosa26-YFP allele (E and F) and homozygous Rosa26-YFP alleles (F) were 
treated with tamoxifen for 5 d, and then splenocytes were analyzed. (E) 
Expression of YFP in NK cells; T cells; B cells; and non-NK, non-T, and non-B 
cells (predominantly myeloid cells) in the spleen. (F) Expression of YFP by 
NK cells in the spleen. Data are representative of more than five experi-
ments (n = 2–6 in each experiment). Bold and thin lines represent cells in 
mice treated with tamoxifen and cells in untreated mice, respectively.
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pared with the frequencies of total YFP+ NK cells in naive 
uninfected NKp46-CreERT2 x Rosa26-YFP Tg mice at 1 
mo after tamoxifen administration, a significantly higher per-
centage and absolute number of YFP+Ly49H+ memory NK 
cells were present in the lymphoid organs and, importantly, in 
the salivary glands, which is the site of persistent viral repli-
cation, in MCMV-infected mice (Fig. 2 E and not depicted). 
In contrast, cytokine-activatedYFP+Ly49H− NK cells did not 
increase in percentage or absolute number in the lymphoid 
organs during MCMV infection, and only a small number of 
YFP+Ly49H− NK cells were detected in the salivary glands 
(Fig. 2 E and not depicted). A significantly higher percent-
age of YFP+Ly49H+ memory NK cells displaying a memory 
immunophenotype (KLRG1highLy6C+DNAM-1low) were 
present in the lymphoid organs and salivary glands compared 
with cytokine-activated YFP+Ly49H− NK cells (Fig.  2  F). 
α4β1 integrin, which is composed of CD49d and CD29, is 
known to be an important adhesion molecule for localization 
of leukocytes in the salivary glands (Kunkel and Butcher, 
Figure 2. nK cells differentiate into memory nK cells and cy-
tokine-activated nK cells after McMV infection. NKp46-CreERT2 
Tg mice with a heterozygous Rosa26-YFP allele (A) or homozygous 
Rosa26-YFP alleles (B–H) were treated with tamoxifen on days 0–4 and 
infected or not with MCMV on day 0. (A) The number of YFP+ NK cells 
and YFP− NK cells in the blood over the course of infection. Data were 
pooled from two experiments (n = 7 in each group). *, P < 0.05; **, P < 
0.01; ***, P < 0.005 versus Ly49H− cells. (B) Expression of Ly49H and KLRG1 
on YFP+ NK cells in the spleens of uninfected and infected mice on day 
27 p.i. The percentages of Ly49H+KLRG1high NK cells and Ly49H−KLRG1high 
NK cells are shown. Expression of KLRG1 on YFP+ NK cells in the spleens 
of naive uninfected mice and on YFP+Ly49H+ memory NK cells and cyto-
kine-activated YFP+Ly49H− NK cells from MCMV-infected mice. Bold solid 
lines, bold dashed lines, thin solid lines, and thin dashed lines represent 
memory NK cells, cytokine-activated NK cells, naive Ly49H+ NK cells, and 
naive Ly49H− NK cells, respectively. (C) Phenotype of YFP+ NK cells in the 
spleens of naive uninfected mice, and YFP+Ly49H+KLRG1high memory NK 
cells and cytokine-activated YFP+Ly49H−KLRG1high NK cells in the spleens 
of infected mice on day 25–32 p.i. (D) Expression of Granzyme B in YFP+ 
NK cells in the spleens of naive uninfected mice, and in memory YFP+ 
Ly49H+KLRG1high NK cells and cytokine-activated YFP+Ly49H−KLRG1high NK 
cells in the spleens of infected mice on day 32 p.i. Bold solid lines, bold 
dashed lines, and thin lines represent memory NK cells, cytokine-activated 
NK cells, and naive NK cells, respectively. Filled histograms represent stain-
ing with an isotype-matched control Ig. Data are representative of more 
than five experiments (n = 2–6 in each experiment). (E) The percentages 
of YFP+ NK cells in naive uninfected mice on days 25–27 after tamoxi-
fen treatment and the percentages of YFP+Ly49H+KLRG1high memory NK 
cells and cytokine-activated YFP+Ly49H−KLRG1high NK cells in the organs of 
tamoxifen-treated infected mice on days 25–27 p.i. *, P < 0.05; **, P < 0.01. 
(F) The percentages of YFP+Ly49H+ NK cells and YFP+Ly49H− NK cells ex-
pressing a memory phenotype KLRG1highLy6C+DNAM-1low in the organs of 
tamoxifen-treated infected mice on days 25–27 p.i. Data are pooled from 
six experiments (n = 4–8 in each group). *, P < 0.01 versus memory cells. 
(G) Expression of CD49d on YFP+ NK cells in the blood of naive uninfected 
mice on day 25 after tamoxifen treatment and on YFP+Ly49H+KLRG1high 
memory NK cells and cytokine-activated YFP+Ly49H−KLRG1high NK cells in 
the blood of infected mice on day 25 p.i. Bold solid lines, bold dashed lines, 
and thin lines represent memory NK cells, cytokine-activated NK cells, and 
naive NK cells, respectively. A filled histogram represents staining with a 
control isotype-matched control Ig. Mean fluorescence intensity (MFI) of 
CD49d staining of NK cells are shown in H. Data are representative of two 
experiments (n = 4–6 in each group). *, P < 0.01 versus memory cells. P-values 
were calculated by a Student’s t test. Error bars show SEM.
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2002, 2003). YFP+Ly49H+KLRG1high memory NK cells ex-
pressed higher amount of CD49d than cytokine-activated 
YFP+Ly49H−KLRG1high NK cells (Fig. 2, G and H). Both 
NK cell subsets equivalently expressed high amounts of CD29 
on their surfaces (unpublished data). These results demonstrate 
that MCMV infection induces differentiation of two distinct 
long-lived NK cell subsets, the MCMV-specific memory 
Ly49H+ NK cells and cytokine-activated Ly49H− NK cells.
IL-12 is required for the optimal differentiation of both 
memory Ly49H+ nK cells and cytokine-activated Ly49H− nK 
cells during McMV infection
The differentiation of memory Ly49H+ NK cells during 
MCMV infection requires IL-12 (Sun et al., 2012). We 
examined the requirement of IL-12 for the generation of 
cytokine-activated Ly49H−KLRG1high NK cells in vivo 
during MCMV infection. When NKp46-CreERT2 x Ro-
sa26-YFP Tg mice were infected with MCMV and treated 
with tamoxifen, neutralization of IL-12 on the day before 
MCMV infection and on days 3 and 6 p.i. significantly im-
paired the differentiation of both YFP+Ly49H+KLRG1high 
memory NK cells and cytokine-activated YFP+Ly49H−KL-
RG1high NK cells (Fig. 3). The neutralization of IL-12 did 
not affect the phenotype of Ly49H+KLRG1high memory 
NK cells or cytokine-activated Ly49H−KLRG1high NK 
cells (unpublished data), but did affect the magnitude of 
their response. These findings indicate that IL-12 is essen-
tial for the optimal differentiation of both Ly49H+ mem-
ory NK cells and cytokine-activated Ly49H− NK cells 
during MCMV infection.
cytokine-activated nK cells persist longer than memory nK 
cells in an McMV-free environment
We investigated the persistence of MCMV-primed Ly49H+ 
memory NK cells and cytokine-activated Ly49H− NK cells in 
an MCMV-free environment. NKp46-CreERT2 x Rosa26-td-
Tomato Tg mice were treated with tamoxifen to label tdTo-
mato+ NK cells in naive uninfected mice. NKp46-CerERT2 
x Rosa26-YFP Tg were infected or not with MCMV and 
treated with tamoxifen. YFP+ NK cells from naive unin-
fected mice or YFP+ NK cells from MCMV-infected mice, 
which included both YFP+Ly49H+KLRG1high memory NK 
cells and cytokine-activated YFP+Ly49H−KLRG1high NK 
cells, were mixed with the tdTomato+ NK cells from naive 
uninfected mice as competitor NK cells, and then adop-
tively transferred into Rag1-deficient B6 mice (Fig.  4  A). 
A smaller number of MCMV-primed YFP+ NK cells, in 
particular YFP+Ly49H+KLRG1high memory NK cells, was 
detected in Rag1-deficient recipient mice on day 5 after 
transfer compared with YFP+ NK cells and tdTomato+ com-
petitor NK cells from tamoxifen-treated naive uninfected 
mice (Fig.  4, B and C). YFP+Ly49H+KLRG1high memory 
NK cells and cytokine-activated YFP+Ly49H−KLRG1high 
NK cells were less proliferative in Rag1-deficient mice, as 
demonstrated by the smaller percentages of Ki67+ YFP+ 
Ly49H+KLRG1high memory NK cells and cytokine- 
activated YFP+Ly49H−KLRG1high NK cells compared with 
YFP+ NK cells and tdTomato+ NK cells from tamoxi-
fen-treated, naive uninfected mice on day 5 after transfer 
(Fig.  4  D). Consistent with the poor persistence of YFP+ 
Ly49H+KLRG1high memory NK cells in MCMV-uninfected 
Rag1-deficient mice, YFP+Ly49H+KLRG1high memory NK 
cells expressed lower amounts of Bcl-2 as compared with 
cytokine-activated YFP+Ly49H−KLRG1high NK cells and 
YFP+ NK cells from naive uninfected mice on day 5 after 
transfer (Fig. 4, E and F). Furthermore, higher percentages 
of Annexin V+ NK cells were present in the YFP+Ly49H+ 
KLRG1high memory NK cell subset than those in the cy-
tokine-activated YFP+Ly49H−KLRG1high NK cell subset on 
day 5 after transfer (Fig. 4 G).
To confirm the inefficient persistence of MCMV- 
primed NK cell subsets in MCMV-free hosts, YFP+ NK 
cells from naive uninfected mice and MCMV-primed 
YFP+ NK cells from infected mice were co-cultured with 
CD45.1+ WT B6 NK cells from naive uninfected mice 
in the presence of IL-15 for 4 d. YFP+Ly49H+KLRG1high 
memory NK cells and cytokine-activated YFP+Ly49H− 
KLRG1high NK cells responded to IL-15 in vitro less ef-
ficiently than YFP+ NK cells from naive uninfected mice 
(Fig.  4, H and I). Consistent with the poor persistence of 
YFP+Ly49H+KLRG1high memory NK cells in Rag1-de-
ficient mice, YFP+Ly49H+KLRG1high memory NK cells 
showed an impaired response to IL-15 as compared with cy-
tokine-activated YFP+Ly49H−KLRG1high NK cells (Fig.  4, 
H and I). YFP+Ly49H+KLRG1high memory NK cells and 
cytokine-activated YFP+Ly49H−KLRG1high NK cells ex-
pressed lower amounts of CD122 and CD132 on their cell 
surfaces than YFP+ NK cells from naive uninfected mice, 
Figure 3. IL-12 is required for the optimal differentiation of mem-
ory nK cells and cytokine-activated nK cells. NKp46-CreERT2 Tg mice 
with homozygous Rosa26-YFP alleles were treated daily with tamoxifen on 
days 0–4 and infected with MCMV on day 0. Mice were injected with 200 
µg control Ig or anti–IL-12 neutralizing mAb on the day before infection 
and on day 3 and 6 p.i. The percentages of YFP+Ly49H+KLRG1high mem-
ory NK cells and cytokine-activated YFP+Ly49H−KLRG1high NK cells in the 
spleens on day 26 p.i. are shown. Data are pooled from two experiments 
(n = 4–5 in each group). *, P < 0.01; **, P < 0.005 versus control Ig. P-values 
were calculated by a Student’s t test. Error bars show SEM.
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Figure 4. cytokine-activated nK cells preferentially persist in an McMV-free environment. (A) NKp46-CreERT2 Tg mice with a heterozygous 
Rosa26-tdTomato allele or homozygous Rosa26-YFP alleles were treated with tamoxifen for 5 d and infected or not with MCMV on day 0. On day 
27 after treatment with tamoxifen, tdTomato+ NK cells from naive uninfected mice were mixed with YFP+ NK cells from naive uninfected mice and 
with MCMV-primed YFP+ NK cells from infected mice, and then adoptively transferred into Rag1-deficient B6 mice. Donor NK cells were analyzed 
on day 5 after the transfer. (B) Expression of Ly49H and KLRG1 on donor tdTomato+ NK cells and YFP+ NK cells before transfer and in the spleens of 
Rag1-deficient recipient mice on day 5 after transfer. Splenocytes on day 5 after transfer were fixed and permeabilized for staining of Ki67. Thus, 
the fluorescence of tdTomato and YFP decreases as compared with before transfer. Data are representative of two experiments (n = 3–4 in each 
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which may partially explain their poor persistence and ho-
meostatic proliferation in an MCMV-free environment in 
vivo and their impaired responses to IL-15 in vitro (Fig. 4, 
J and K). These results demonstrate that in vivo cytokine–
activated Ly49H− NK cells persist longer than memory 
Ly49H+ NK cells in an MCMV-free environment, whereas 
memory Ly49H+ NK cells predominate over cytokine-acti-
vated NK cells in chronically MCMV-infected mice.
Memory Ly49H+ nK cells exert 
augmented antitumor activity
To evaluate effector functions of Ly49H+KLRG1high mem-
ory NK cells and cytokine-activated Ly49H−KLRG1high 
NK cells, YFP+ NK cells from naive uninfected NKp46-
CreERT2 Tg x Rosa26-YFP mice treated with tamoxifen 
and MCMV-primed YFP+ NK cells from NKp46-CreERT2 
Tg x Rosa26-YFP mice treated with tamoxifen and in-
fected with MCMV were stimulated in vitro with IL-12 
plus IL-18 by cross-linking NK1.1, or by co-culture with 
RMA transfectants expressing m157 or an NKG2D ligand, 
Rae1γ. A significantly lower frequency of YFP+Ly49H+ 
KLRG1high memory NK cells and cytokine-activated 
YFP+Ly49H−KLRG1high NK cells produced IFN-γ com-
pared with naive YFP+ NK cells after stimulation with IL-12 
plus IL-18 (Fig. 5, A and B). These results are consistent with 
our prior study reporting reduced IFN-γ production from 
MCMV-primed memory Ly49H+ NK cells after IL-12 
stimulation in the absence of Ly49H signaling (Min-Oo 
and Lanier, 2014) and a recent study in which human NK 
cells with memory features demonstrated a poor ability to 
produce IFN-γ after IL-12 plus IL-18 stimulation (Liu et 
al., 2016). Naive YFP+ NK cells, YFP+Ly49H+KLRG1high 
memory NK cells, and cytokine-activated YFP+Ly49H− 
KLRG1high NK cells expressed NK1.1, NKp46, 2B4, TIG IT, 
and Ly49C and/or Ly49I equivalently (unpublished data). 
YFP+Ly49H+KLRG1high memory NK cells and cyto-
kine-activated YFP+Ly49H−KLRG1high NK cells equiva-
lently expressed NKG2D, at levels slightly higher compared 
with naive YFP+ NK cells (unpublished data). However, a 
significantly higher frequency of YFP+Ly49H+KLRG1high 
memory NK cells degranulated and produced IFN-γ 
compared with both naive YFP+ NK cells and cytokine- 
activated YFP+Ly49H−KLRG1high NK cells after NK1.1 
cross-linking or stimulation via NKG2D with RMA trans-
fectants expressing Rae1γ (Fig. 5, A and B). A slightly larger 
fraction of cytokine-activated YFP+Ly49H−KLRG1high 
NK cells also showed degranulation and IFN-γ produc-
tion compared with naive YFP+ NK cells after NK1.1 li-
gation (Fig. 5, A and B). To examine the effector functions 
of MCMV-primed NK cell subsets in vivo, YFP+ NK cells 
from naive uninfected mice and YFP+Ly49H+KLRG1high 
memory NK cells and cytokine-activated YFP+Ly49H− 
KLRG1high NK cells from MCMV-infected mice were 
purified and transferrred into T cell–depleted DAP10 and 
DAP12 double-deficient B6 mice, which lack expression 
of NKG2D. These recipient mice were then injected with 
a mixture of NK cell–resistant RMA cells, NK cell–sen-
sitive Rae1γ-transfected RMA cells, and NK cell–sensi-
tive RMA-S cells. Recipient mice receiving YFP+Ly49H+ 
KLRG1high memory NK cells exhibited significantly im-
proved clearance of Rae1γ−RMA cells, as compared with 
recipient mice that received naive YFP+ NK cells or cyto-
kine-activated YFP+Ly49H−KLRG1high NK cells (Fig. 5, C 
and D). These results demonstrate that memory Ly49H+ 
NK cells exert enhanced effector functions in vitro and 
demonstrate augmented antitumor activity in vivo.
experiment). (C) The number of donor NK cells in the spleens of Rag1-deficient recipient mice on day 5 after transfer. The y axis represents the num-
ber of donor NK cells detected in the spleens of Rag1-deficient mice on day 5 compared with the number of donor NK cells adoptively transferred 
into Rag1-defiicent mice. *, P < 0.01 versus memory YFP+ cells. (D) The percentages of Ki67+ donor NK cells on day 5. Data were pooled from two 
experiments (n = 6–7 in each group). *, P < 0.05 versus naive tdTomato+ cells and naive YFP+ cells. (E–G) NKp46-CreERT2 Tg mice with homozygous 
Rosa26-YFP alleles were treated with tamoxifen for 5 d and infected or not with MCMV on day 0. On day 27 after tamoxifen treatment, YFP+ NK 
cells isolated from naive uninfected mice and MCMV-primed YFP+ NK cells were adoptively transferred into Rag1-deficient B6 mice. Donor NK cells 
were analyzed on day 5 after the transfer. (E) Expression of Bcl-2 in donor NK cells on day 5. Bold solid lines, bold dashed lines, and thin lines repre-
sent memory NK cells, cytokine-activated NK cells, and naive NK cells, respectively. A filled histogram represents staining with an isotype-matched 
control Ig. Data were representative of two experiments (n = 2–3 in each experiment). MFI of Bcl-2 staining in NK cells is shown in F. (G) The per-
centages of Annexin V+ donor NK cells on day 5. Data were pooled from two experiments (n = 5 in each group). *, P < 0.05 versus memory cells. 
(H–K) NKp46-CreERT2 Tg mice with homozygous Rosa26-YFP alleles were treated with tamoxifen for 5 d and infected or not with MCMV on day 0. 
(H and I) On day 25 after tamoxifen treatment, YFP+ NK cells from naive uninfected mice or MCMV-primed YFP+ NK cells were mixed with CD45.1+ 
WT B6 NK cells from naive uninfected mice, labeled with CellTrace Violet, and cultured in the presence of 2 or 10 ng/ml IL-15 for 4 d. (H) Cell divi-
sions of NK cells on day 4. Filled histograms represent naive YFP+ NK cells. Bold and thin lines represent YFP+Ly49H+KLRG1high memory NK cells and 
cytokine-activated YFP+Ly49H−KLRG1high NK cells, respectively. The number of cell divisions of NK cells was quantified in I. Data are representative of 
two experiments (n = 3–6 in each experiment). *, P < 0.05 versus memory cells. (J) Expression of CD122 and CD132 on YFP+ NK cells in the spleens 
of naive uninfected mice and YFP+Ly49H+KLRG1high memory NK cells and cytokine-activated YFP+Ly49H−KLRG1high NK cells in the spleens of infected 
mice on days 25–27 p.i. Bold solid lines, bold dashed lines, and thin lines represent memory NK cells, cytokine-activated NK cells, and naive NK cells, 
respectively. Filled histograms represent staining with an isotype-matched control Ig. Data are representative of more than three experiments (n = 
2–3 in each experiment). MFI of CD122 and CD132 staining of NK cells are shown in K. Data were pooled from three experiments (n = 6–7 in each 
group). *, P < 0.005 versus naive cells. P-values were calculated by a Student’s t test. Error bars show SEM.
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Memory nK cells and cytokine-activated nK cells 
show impaired IFn-γ production after Listeria 
monocytogenes infection
To assess functional responses of naive NK cells and MC-
MV-primed NK cells in response to infection with L. mono-
cytogenes, we analyzed the activation and IFN-γ production 
in tamoxifen-treated uninfected and previously MCMV-in-
fected NKp46-CerERT2 Tg x Rosa26-YFP mice on day 
1.5 after L. monocytogenes infection. The percentages of 
YFP+ NK cells expressing IFN-γ after L. monocytogenes in-
fection were significantly higher in the MCMV-uninfected 
mice than in the YFP+Ly49H+ memory NK cells and cy-
tokine-activated YFP+Ly49H− NK cells in MCMV-infected 
mice (Fig. 6, A and B). YFP+Ly49H+ memory NK cells and 
cytokine-activated YFP+Ly49H− NK cells showed impaired 
activation after L. monocytogenes infection compared with 
naive YFP+ NK cells, as reflected by a lower frequency of 
NK cells up-regulating CD69 (Fig. 6, C and D). These find-
ings demonstrate that MCMV-primed NK cell subsets are 
diminished in their responses to cytokine-driven bystander 
responses to L. monocytogenes infection.
Ly49H signaling is required for differentiation of memory 
Ly49H+ nK cells during McMV infection
To determine whether an activating signal through Ly49H 
in addition to exposure to inflammatory cytokines during 
MCMV infection is essential for the generation of memory 
NK cells, NKp46-CreERT2 Tg x Rosa26-YFP mice were 
infected with WT MCMV or MCMV lacking the m157 
gene (Δm157 MCMV) and treated with tamoxifen. The phe-
notype and effector functions of YFP+Ly49H+KLRG1high 
NK cells in WT MCMV-infected mice and Δm157 MCMV- 
infected mice were compared. Although infection with 
Δm157 MCMV induced the up-regulation of KLRG1 on 
YFP+ NK cells equivalent to WT MCMV, lower percent-
ages of YFP+Ly49H+KLRG1high NK cells were present in 
mice infected with Δm157 MCMV compared with WT 
MCMV at 1 mo p.i. (Fig.  7 A). YFP+Ly49H+ NK cells in 
mice infected with WT and Δm157 MCMV showed a ma-
Figure 5. Memory nK cells exert augmented antitumor activ-
ity. NKp46-CreERT2 Tg mice with homozygous Rosa26-YFP alleles were 
treated with tamoxifen for 5 d and infected or not with WT MCMV on 
day 0. (A and B) Degranulation (A) and IFN-γ production (B) of naive YFP+ 
NK cells from naive uninfected mice and YFP+Ly49H+KLRG1high memory NK 
cells and cytokine-activated YFP+Ly49H−KLRG1high NK cells from infected 
mice after culture in the presence of IL-12 and IL-18, stimulation with 
anti-NK1.1 mAb, and co-culture with RMA transfectants expressing m157 
or Rae1γ. Data are representative of three experiments (n = 3–4 in each 
experiment). *, P < 0.05. (C) Splenic YFP+ NK cells from naive uninfected 
mice, and YFP+Ly49H+KLRG1high memory NK cells and cytokine-activated 
YFP+Ly49H−KLRG1high NK cells from infected mice were isolated on day 
26 p.i. 15,000 YFP+ NK cells were transferred into T cell–depleted DAP10 
and DAP12-double deficient recipient B6 mice. CellTrace Violet–labeled 
RMA-Rae1γ transfectants and RMA-S cells were mixed with RMA cells 
at a 1:1:1 (105 of each cell line) ratio, and injected intraperitoneally into 
these recipient mice on the day of NK cell transfer. An aliquot of the mixed 
tumor cells was cultured as a control. Proportions of these tumor cells 
(RMA, H-2Kb+ CellTrace Violet−; RMA-Rae1γ transfectants, H-2Kb+ CellTrace 
Violet+; and RMA-S cells, H-2Kb− CellTrace Violet+) in the peritoneal cavity 
were analyzed at 48 h after the injection. Data are representative of two 
experiments (n = 3 in each experiment). (D) NKG2D-mediated cytotoxicity 
against RMA-Rae1γ transfectants was quantified as the number of RMA-
Rae1γ transfectants compared with the number of RMA cells detected in 
the peritoneal cavity at 48 h after injection. The y axis represents the clear-
ance of RMA-Rae1γ transfectants in the peritoneal cavity of recipient mice 
receiving donor NK cells normalized to that of recipient mice not receiving 
donor NK cells expressed as a relative quantity. Data were pooled from two 
experiments (n = 6 in each group). *, P < 0.01 versus memory cells. P-values 
were calculated by a Student’s t test. Error bars show SEM.
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ture phenotype (CD11b+CD27−), up-regulated Granzyme 
B, and down-modulated CD122 and CD132 (unpublished 
data). However, significantly fewer of these YFP+Ly49H+ NK 
cells in Δm157 MCMV-infected mice displayed a memory 
immunophenotype (KLRG1highLy6C+DNAM-1low), but dis-
played a phenotype similar to the cytokine-activated YFP+ 
Ly49H−KLRG1high NK cells in WT MCMV-infected mice 
(Fig.  2  C) and distinct from the YFP+Ly49H+KLRG1high 
memory NK cells in WT MCMV-infected mice (Fig. 7 A). 
To examine the effector functions of Δm157 MCMV-primed 
YFP+Ly49H+KLRG1high NK cells, YFP+ NK cells from naive 
uninfected mice, YFP+Ly49H+KLRG1high memory NK cells 
from WT MCMV-infected mice, and MCMV-primed YFP+ 
Ly49H+KLRG1high NK cells from Δm157 MCMV-infected 
mice were stimulated in vitro with IL-12 plus IL-18 by 
cross-linking NK1.1 and by co-culture with RMA transfec-
tants expressing m157. Similar to cytokine-activated YFP+ 
Ly49H−KLRG1high NK cells in WT MCMV-infected mice 
(Fig.  5, A and B), Δm157 MCMV-primed YFP+Ly49H+ 
KLRG1high NK cells secreted reduced amount of IFN-γ in 
response to IL-12 plus IL-18 and showed a slightly enhanced 
frequency of cells that degranulated and produced IFN-γ after 
cross-linking of NK1.1 compared with YFP+ NK cells from 
naive uninfected mice (Fig. 7, B and C). However, fewer of 
the YFP+Ly49H+KLRG1high NK cells from Δm157 MCMV- 
primed mice degranulated and produced IFN-γ compared 
with YFP+Ly49H+KLRG1high memory NK cells from WT 
MCMV-infected mice after NK1.1 ligation or Ly49H stim-
ulation with m157 RMA transfectants (Fig.  7, B and C). 
These findings demonstrate that Ly49H signaling is required 
for the differentiation of bona fide MCMV-induced memory 
Ly49H+ NK cells with enhanced effector functions.
dIscussIon
Here, by using novel transgenic mice carrying inducible Cre 
under the control of expression by the Ncr1 gene, we found 
that two distinct NK cell subsets are generated by MCMV in-
fection. One is an activating receptor ligand–driven memory 
NK cell and the other is an inflammatory cytokine-activated 
NK cell. Further, we directly compared the in vitro and in 
vivo functional properties and fate of activating receptor sig-
nal–driven Ly49H+KLRG1high memory NK cells versus cy-
tokine-activated Ly49H−KLRG1high NK cells, both of which 
were generated in the same environment. Although prior 
studies have addressed the phenotypes, effector functions, 
persistence, and tissue distribution of mouse NK cells gener-
ated after MCMV infection in vivo or by in vitro activation 
with cytokines and then adoptive transfer into congenic mice 
(Cooper et al., 2009; Sun et al., 2009, 2010; Ni et al., 2012; 
van Helden et al., 2012), no studies have directly compared 
the functions and tracked the fate of activating receptor sig-
nal–driven memory NK cells versus cytokine-activated NK 
cells that are generated in vivo in a physiologically relevant 
viral infection. Our studies revealed that activating receptor 
signal–driven Ly49H+KLRG1high memory NK cells have 
augmented effector functions in vitro and in vivo, whereas 
cytokine-activated Ly49H−KLRG1high NK cells persist lon-
ger in an MCMV-free environment.
MCMV establishes latency after clearance of the pri-
mary infection and replicates chronically in the salivary glands 
(Vliegen et al., 2003). Prior studies have demonstrated that 
NK cells, T cells, and neutralizing antibodies against MCMV 
are critical for preventing recurrence and dissemination of 
MCMV from the salivary glands of latently infected mice 
(Jonjić et al., 1994; Polić et al., 1998). One of the notable 
differences between Ly49H+KLRG1high memory NK cells 
and cytokine-activated Ly49H−KLRG1high NK cells is their 
tissue distribution. Although both Ly49H+ and Ly49H− NK 
cells exist in the salivary glands of naive uninfected mice, 
Ly49H+KLRG1high memory NK cells, but not cytokine-ac-
tivated Ly49H−KLRG1high NK cells, predominantly resided 
Figure 6. Memory nK cells and cytokine-activated nK cells show 
diminished responses to L. monocytogenes infection. NKp46-CreERT2 
Tg mice with homozygous Rosa26-YFP alleles were treated with tamoxifen 
on days 0–4 and infected or not with MCMV on day 0. On day 25, these 
mice were infected intravenously with 5 × 104 CFU L. monocytogenes, and 
YFP+ NK cells in naive MCMV-uninfected mice and YFP+Ly49H+KLRG1high 
memory NK cells and cytokine-activated YFP+Ly49H−KLRG1high NK cells in 
MCMV-infected were analyzed on day 1.5 after infection with L. monocy-
togenes. (A) IFN-γ+ in naive NK cells, memory NK cells, and cytokine-ac-
tivated NK cells in the spleens of L. monocytogenes–infected mice. Bold 
solid lines, bold dashed lines, and thin lines represent memory NK cells, 
cytokine-activated NK cells, and naive NK cells, respectively. A filled his-
togram represents NK cells in naive uninfected mice. The percentages of 
IFN-γ+ NK cells are quantified in B. (C) CD69 on naive NK cells, memory NK 
cells, and cytokine-activated NK cells in the spleens of L. monocytogenes–
infected mice. Bold solid lines, bold dashed lines, and thin lines represent 
memory NK cells, cytokine-activated NK cells, and naive NK cells, respec-
tively. A filled histogram represents staining with an isotype-matched 
control Ig. MFI of CD69 staining of NK cells is shown in D. Data were rep-
resentative of two experiments (n = 4 in each experiment) in A and C. 
Data were pooled from two experiments (n = 4 in each group) in B and 
D. *, P < 0.05 versus naive cells. P-values were calculated by a Student’s t 
test. Error bars show SEM.
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in the salivary glands of MCMV-infected mice. These find-
ings suggest that the preferential accumulation of Ly49H+ 
KLRG1high memory NK cells in the salivary glands might 
contribute to suppression of reactivation of MCMV in la-
tently infected hosts. Despite our findings that Ly49H+ 
KLRG1high memory NK cells predominate over cytokine- 
activated Ly49H−KLRG1high NK cells in the organs of 
MCMV-infected mice, cytokine-activated Ly49H−KLRG1high 
NK cells exhibited better persistence than memory Ly49H+ 
KLRG1high NK cells in MCMV-free recipient mice. A possi-
ble explanation is that persistence of MCMV-specific Ly49H+ 
KLRG1high memory NK cells is dependent on the equilib-
rium between viral replication and dissemination of MCMV 
and subsequent reactivation, causing proliferation of Ly49H+ 
KLRG1high memory NK cells.
The previously described mouse cytokine-induced 
memory-like NK cells were generated by culturing NK 
cells in vitro with pharmacological amounts of a combi-
nation of cytokines (Cooper et al., 2009; Ni et al., 2012). 
However, there is no evidence that these cytokine-induced 
memory-like NK cells are generated in vivo in physiolog-
ical situations. Here, we demonstrated that cytokine-acti-
vated Ly49H−KLRG1high NK cells are generated in vivo after 
MCMV infection. However, the functional properties of in 
vivo MCMV-induced cytokine-activated NK cells are dif-
ferent than the in vitro–generated cytokine-induced mem-
ory-like NK cells. The in vitro–derived cytokine-induced 
memory-like NK cells displayed enhanced IFN-γ production 
in response to ex vivo stimulation with cytokines, cross-link-
ing of activating receptors, and tumor target cells, although 
they did not exert enhanced cytotoxicity (Cooper et al., 2009; 
Ni et al., 2012). However, we have demonstrated that in vivo 
MCMV-induced cytokine-activated NK cells display both 
enhanced degranulation and IFN-γ production in response 
to stimulation by cross-linking activating receptors and tumor 
target cells, but demonstrated poor IFN-γ production in re-
sponse to IL-12 plus IL-18. Thus, the in vivo–generated cyto-
kine-activated NK cells are not necessarily the counterparts 
of the cytokine-induced memory-like NK cells that were 
generated by in vitro culture.
Human CD94-NKG2Chigh NK cells preferentially 
expand during acute HCMV infection, and there is an el-
evated number and long-term persistence of mature CD94- 
NKG2ChighCD57+ NK cells in HCMV-seropositive indi-
viduals (Gumá et al., 2004; Lopez-Vergès et al., 2011; Foley 
et al., 2012a,b). These CD94-NKG2Chigh NK cells demon-
strate enhanced cytokine production and degranulation 
when stimulated ex vivo, and there is a secondary expansion 
of CD94-NKG2ChighCD57+ NK cells in response to reacti-
vation of HCMV in immunosuppressed transplant patients 
(Gumá et al., 2004; Lopez-Vergès et al., 2011; Foley et al., 
2012a,b). Intriguingly, in some HCMV-seropositive individ-
uals, there is an expansion of a unique subset of NK cells 
that lack expression of FcεRIγ. These NK cells predomi-
nantly express the CD94-NKG2C receptor and have enhanced 
anti body-dependent cellular cytotoxicity activity against an-
tibody-coated HCMV-infected cells (Zhang et al., 2013). 
These findings support the hypothesis that activating signals 
through NKG2C drive the differentiation of human CD94- 
NKG2Chigh memory NK cells, similar to the m157-driven 
Ly49H+ memory NK cells in MCMV-infected mice (Gumá 
Figure 7. Ly49H signaling is required for the differentiation of 
functional memory nK cells. NKp46-CreERT2 Tg mice with homozygous 
Rosa26-YFP alleles were treated with tamoxifen for 5 d and infected or un-
infected with WT or Δm157 MCMV on day 0. (A) Phenotype of YFP+ NK cells 
in the spleens of naive uninfected mice, YFP+Ly49H+KLRG1high memory NK 
cells in the spleens of WT MCMV-infected mice, and MCMV-primed YFP+ 
Ly49H+KLRG1high NK cells in the spleens of Δm157 MCMV-infected mice 
on days 25–27 p.i. The percentages of Ly49H+KLRG1high NK cells are shown. 
(B and C) Degranulation (B) and IFN-γ production (C) of YFP+ Ly49H+ NK 
cells from naive uninfected mice, YFP+Ly49H+KLRG1high memory NK cells 
from WT MCMV-infected mice, and MCMV-primed YFP+Ly49H+KLRG1high 
NK cells from Δm157 MCMV-infected mice after culture with IL-12 and 
IL-18, stimulation with anti-NK1.1 mAb, and co-culture with RMA cells 
expressing m157. Data are representative of two experiments (n = 3 in 
each experiment). *, P < 0.05. P-values were calculated by a Student’s t 
test. Error bars show SEM.
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et al., 2004; Lopez-Vergès et al., 2011; Foley et al., 2012a,b). 
Additionally, these findings strongly suggest that an activating 
signal through the CD94-NKG2C-DAP12 receptor directly 
and quantitatively controls the differentiation of long-lived 
CD94-NKG2Chigh NK cells in the course of HCMV infec-
tion and that these cells may represent an activating receptor 
ligand–driven memory NK cell subset in humans.
HCMV-seropositive healthy individuals homozygously 
carrying the KLRC2 gene that encodes NKG2C show a sig-
nificantly higher frequency and number of CD94-NKG2C+ 
NK cells than those carrying a heterozygous deletion of 
KLRC2 (Noyola et al., 2012; Muntasell et al., 2013). In 
KLRC2 hemizygous individuals, KLRC2+/− NK cells ex-
hibit diminished calcium influx, degranulation, and prolifer-
ation upon NKG2C ligation compared with KLRC2+/+ NK 
cells (Muntasell et al., 2013). In response to acute HCMV 
infection, NK cells in patients transplanted with umbilical 
cord blood obtained from donors carrying a homozygous 
deletion of KLRC2 demonstrated an expansion of mature 
NK cells expressing an activating KIR, suggesting that re-
ceptors other than CD94-NKG2C may also drive NK cell 
differentiation (Della Chiesa et al., 2014). Similarly, in some 
HCMV-seropositive individuals carrying a heterozygous or 
homozygous deletion of KLRC2 there is also an expan-
sion of the unique subset of NK cells lacking FcεRIγ (Liu 
et al., 2016; Muntasell et al., 2016). KLRC2−/− NK cells in 
HCMV-seropositive individuals display a mature phenotype 
(LIL RB1highCD7lowCD161lowCD57highFcεR1γlowNKG2A−), 
which is similar but not identical to the CD94-NKG2Chigh 
NK cell subset in HCMV-seropositive KLRC2+/+ individuals 
(Liu et al., 2016). More importantly, these mature KLRC2−/− 
NK cells share enhanced TNF and IFN-γ production against 
antibody-coated target cells, impaired IFN-γ production after 
IL-12 plus IL-18 stimulation, and an epigenetic remodeling 
associated with demethylation of CpG motifs in the IFNG 
promoter region, similar to memory CD94-NKG2Chigh NK 
cells in HCMV-seropositive KLRC2+/+ individuals (Liu 
et al., 2016). The identification of an NK cell subset with 
memory features in HCMV-seropositive individuals lacking 
expression of NKG2C raises the possibility that inflamma-
tory cytokines during HCMV infection may induce the 
differentiation of these mature NKG2C-deficient NK cells 
with augmented effector functions, which is reminiscent 
of the cytokine-activated Ly49H−KLRG1high NK cell sub-
set in MCMV-infected mice.
Of note, both memory NK cells and cytokine-activated 
NK cells have several functional properties that may be ben-
eficial for cancer immunotherapy, including augmented ef-
fector functions against tumors, persistence in vivo, and the 
capacity for secondary expansion. Further studies of the tran-
scriptional signature and epigenetic modifications defining 
these distinct NK cell subsets are needed to better understand 
the critical regulatory factors for the divergence, differentia-
tion, maintenance, and functional properties of these NK cells 
and to provide important insights into the development of ef-
fective NK cell–based vaccination strategies against infectious 
diseases and malignancies.
MaterIaLs and MetHods
Mice
C57BL/6 (B6) mice and congenic CD45.1+ B6 mice 
were purchased from Charles River. FVB/NJ mice were 
purchased from The Jackson Laboratory. Rosa26-YFP 
(Gt(ROSA)26Sortm1(EYFP)Cos; Srinivas et al., 2001), Rosa26-td-
Tomato (Gt(ROSA)26Sortm14(CAG-tdTomato)Hze; Madisen et al., 
2010), Rag1-deficient (Rag1−/−; Mombaerts et al., 1992), and 
DAP10 (Hcst) and DAP12 (Tyrobp) double-deficient (Inui 
et al., 2009) mice on the C57BL/6 background (provided 
by T. Takai, Tohoku University, Japan) were maintained at the 
University of California (San Francisco, San Francisco, CA) 
in accordance with the guidelines of the Institutional Animal 
Care and Use Committee.
Generation of nKp46-creert2 tg mice
The bacterial artificial chromosome (BAC) clone RP23-
267N11 that encodes mouse chromosome 7 was modified 
to insert an internal ribosome entry site (IRES)-CreERT2 
cassette (provided by M. Shlomchik, Yale University School 
of Medicine, New Haven, CT) into the 3′ untranslated 
region of exon 7 of the mouse Ncr1 gene by a BAC 
recombineering technology using reagents, vectors, and 
bacterial strains available from the National Cancer Institute 
(Bethesda, MD; https ://ncifrederick .cancer .gov /research 
/brb /recombineeringInformation .aspx). The recombined 
BAC construct containing the IRES-CreERT2 element in 
the Ncr1 gene locus was microinjected into the pronucleus 
of single-cell fertilized zygotes of FVB/NJ mice. A founder 
mouse carrying the recombined BAC construct in its genome 
was intercrossed with Rosa26-YFP B6 mice or Rosa26-
tdTomato B6 mice. The BAC transgenic mice (NKp46-
CreERT2 Tg mice) carrying the Rosa26-YFP allele or the 
Rosa26-tdTomato allele, which express YFP or tdTomato, 
respectively, upon CreERT2-mediated excision of loxP-
flanked stop codon were treated with tamoxifen (oral gavage of 
200 µg/g body weight in corn oil) for 4 or 5 consecutive days.
McMV and L. monocytogenes infection
A stock of Smith strain MCMV was prepared by homoge-
nizing salivary glands harvested from infected BALB/c mice 
as described previously (Brune et al., 2001). Mice were in-
fected by intraperitoneal injection of 5 × 103 PFU of salivary 
gland virus. In some experiments, Smith strain WT MCMV 
and Δm157 mutant MCMV (Bubić et al., 2004; provided 
by U. Koszinowski, Max von Pettenkofer-Institut, Munich, 
Germany) were prepared by infecting C57BL/6 3T3 cells in 
cell culture as described previously (Bubić et al., 2004). Mice 
were infected by intraperitoneal injection of 5 × 105 PFU 
WT MCMV or 2.5 × 105 PFU Δm157 MCMV. NKp46-
CreERT2 Tg mice carrying the Rosa26-YFP allele were 
treated with tamoxifen for 4 or 5 d after MCMV infection 
o
n
 January 30, 2017
D
ow
nloaded from
 
Published October 24, 2016
Tracking the fate of NK cells after CMV infection | Nabekura and Lanier2756
on day 0. In some experiments, mice were inoculated intra-
peritoneally with 200 µg of a neutralizing mAb against mouse 
IL-12 p40 (clone C17.8) or an isotype-matched control rat 
IgG2a on the day before MCMV infection, and on days 3 and 
6 p.i. L. monocytogenes 10403S strain was grown in brain–
heart infusion broth to an OD600 of 0.2, and mice were in-
fected intravenously with 5 × 104 CFU. Dose was determined 
by CFU assays for each infection.
Preparation of single-cell suspensions and nK cells
Leukocytes were isolated from spleen, bone marrow, blood, 
liver, and salivary glands. Livers were isolated after tissue 
perfusion with PBS and homogenized by using a Dounce 
homogenizer, and lymphocytes were prepared using centrif-
ugation on a 40 and 60% Percoll gradient (GE Healthcare). 
Sublingual glands and submandibular glands were homoge-
nized, and lymphocytes were prepared using centrifugation 
on a 40 and 70% Percoll gradient. NK cells were enriched by 
incubating splenocytes with purified rat mAbs against mouse 
CD4, CD5, CD8, CD19, Gr-1, and Ter119, followed by anti–
rat IgG antibodies conjugated to magnetic beads (QIA GEN), 
as described previously (Nabekura et al., 2014).
Flow cytometry
Fc receptors (CD16 and CD32) were blocked with 2.4G2 
mAb before surface or intracellular staining with the indi-
cated fluorochrome-conjugated mAbs or isotype-matched 
control antibodies (BD, eBioscience, BioLegend, or TON BO 
Biosciences). In some experiments, cells were fixed with Cy-
tofix (BD), followed by permeabilization with 0.1% Triton 
X-100 in PBS, and then stained with Alexa Flour 647–con-
jugated anti-Ki67 (BD). Samples were acquired on a LSR 
II or a FAC SCalibur (BD) and data were analyzed with 
FlowJo software (FlowJo).
adoptive transfer into rag1-deficient mice
NK cells were enriched from spleens of uninfected NKp46-
CreERT2 Tg x Rosa26-tdTomato mice, uninfected NKp46-
CreERT2 Tg x Rosa26-YFP mice, and MCMV-infected 
NKp46-CreERT2 Tg x Rosa26-YFP mice on day 27 p.i. 
30,000–50,000 tdTomato+ NK cells from naive uninfected 
NKp46-CreERT2 Tg x Rosa26-tdTomato mice were 
mixed with 40,000–60,000 YFP+ NK cells from naive un-
infected NKp46-CreERT2 Tg x Rosa26-YFP mice or 
MCMV-primed YFP+ NK cells from MCMV-infected 
NKp46-CreERT2 Tg x Rosa26-YFP mice, and then injected 
intravenously into Rag1-deficient B6 mice. Donor NK cells 
in the spleens of Rag1-deficient recipient mice were analyzed 
on day 5 after the transfer.
In vitro culture
200,000 NK cells from uninfected and MCMV-infected 
NKp46-CreERT2 Tg x Rosa26-YFP mice were mixed with 
5 × 104 CD45.1+ NK cells from uninfected WT B6 mice, la-
beled with 10 µM CellTrace Violet according to the manufac-
turer’s instructions (Invitrogen), and cultured in the presence 
of 2 or 10 ng/ml human IL-15 (R&D Systems) for 4 d at 37°C.
ex vivo stimulation of nK cells
100,000 NK cells were incubated in 96-well tissue cul-
ture plates coated with anti-NK1.1 (clone PK136) or 
isotype-matched control mouse IgG2a as described pre-
viously (Nabekura et al., 2015); incubated with 2.5 ng/ml 
mouse IL-12 and 2.5 ng/ml mouse IL-18 (R&D Systems); 
or co-cultured with 105 RMA, RMA expressing m157, or 
RMA expressing Rae1γ for 5  h at 37°C in the presence 
of PE-conjugated anti-CD107a mAb and GolgiStop (BD), 
followed by staining for surface molecules and intracellular 
IFN-γ as previously described (Nabekura and Lanier, 2014).
In vivo cytotoxic assay
Enriched NK cells were stained with antibodies against TCRβ, 
B220, Ly49H, and KLRG1. NK cells in the spleens of naive 
uninfected NKp46-CreERT2 Tg x Rosa26-YFP mice were 
purified by sorting YFP+KLRG1+ cells gated on non–T cell 
and –B cell lymphocytes by using a FAC SAria III (BD) on day 
21–25 after the tamoxifen injection. Memory NK cells and 
cytokine-activated NK cells in the spleens of MCMV-infected 
NKp46-CreERT2 Tg x Rosa26-YFP mice were purified 
by sorting YFP+Ly49H+KLRG1high cells and YFP+Ly49H− 
KLRG1high cells gated on non–T cell and –B cell lymphocytes 
by using a FAC SAria III on day 26 p.i. 15,000 NK cells were 
injected intraperitoneally into DAP10 and DAP12 double- 
deficient B6 mice. DAP10 and DAP12 double-deficient B6 
mice were depleted of CD4+ and CD8+ T cells on the day 
before transfer of donor NK cells by intraperitoneal injec-
tion of 100 µg of anti-CD4 (clone GK1.5) and 100 µg of 
anti-CD8 (clone 2.43) mAbs. RMA transfectants expressing 
Rae1γ (RMA-Rae1γ) and RMA-S cells were labeled with 
CellTrace Violet, mixed with unlabeled RMA cells at a ratio 
of 1:1:1 (105 of each cell line; a total of 3 × 105 cells), and 
the mixed tumor cells were injected intraperitoneally into 
DAP10- and DAP12-deficient B6 mice on the day of donor 
NK cell transfer. An aliquot of the mixed tumor cells was 
cultured as a control. After 48 h, peritoneal cavity cells were 
collected and stained with anti-NK1.1, anti-Ly49A, and anti– 
H-2Kb mAbs. Tumor cells were gated on the basis of their 
characteristic forward and side light scatter properties, and then 
gated on NK1.1− and Ly49Ahigh cells. The different tumor cell 
types were discriminated by staining of H-2Kb and CellTrace 
Violet: RMA cells, H-2Kb+ CellTrace Violet−; RMA-Rae1γ 
cells, H-2Kb+ CellTrace Violet+; and RMA-S cells, H-2Kb− 
CellTrace Violet+. NKG2D-mediated cytotoxicity against 
RMA-Rae1γ was quantified as the proportion of viable recov-
ered RMA-Rae1γ cells relative to that of RMA cells, and loss 
of RMA-S cells confirmed efficient NK cell cytolytic activity.
statistical methods
The Student’s t test was used to compare results. P < 0.05 was 
considered statistically significant.
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